Log in
Enquire now
Syncromune

Syncromune

Syncromune is a clinical stage biopharmaceutical dedicated to the development of better immunotherapies for metastatic solid tumors.

OverviewStructured DataIssuesContributors

Contents

syncromune.com
Is a
Organization
Organization
Company
Company

Company attributes

Industry
Information technology
Information technology
Biotechnology
Biotechnology
Software as a service (SaaS)
Software as a service (SaaS)
Pharmaceutical industry
Pharmaceutical industry
Location
Fort Lauderdale, Florida
Fort Lauderdale, Florida
B2X
B2B
B2B
CEO
Eamonn Hobbs
Eamonn Hobbs
Founder
Eamonn Hobbs
Eamonn Hobbs
Number of Employees (Ranges)
11 – 50
Email Address
info@syncromune.com
Phone Number
+15187966110
Investors
Wasatch Venture Partners
Wasatch Venture Partners
Total Funding Amount (USD)
100,000,000
Latest Funding Round Date
December 23, 2024
Latest Funding Type
Series A
Series A

Other attributes

Latest Funding Round Amount (USD)
100,000,000
No article content yet.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more companies like Syncromune

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us